Gossamer Bio Inc (GOSS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 9,480 | 95,842 | 0 | 0 | 0 |
| Gross Profit | 9,480 | 95,842 | N/A | N/A | N/A |
| Operating Expenses | 43,399 | 43,755 | 41,959 | 49,027 | 40,490 |
| Operating Income | -33,919 | 52,087 | -41,959 | -49,027 | -40,490 |
| Interest Expense | 2,734 | 2,916 | 3,129 | 3,239 | 3,343 |
| Other Income | 4,718 | 4,496 | 3,160 | 4,118 | 3,825 |
| Pre-tax Income | -31,935 | 53,667 | -41,928 | -48,148 | -40,008 |
| Income Tax | -1,132 | 4,435 | N/A | N/A | N/A |
| Net Income Continuous | -30,803 | 49,232 | -41,928 | -48,148 | -40,008 |
| Net Income | $-30,803 | $49,232 | $-41,928 | $-48,148 | $-40,008 |
| EPS Basic Total Ops | -0.14 | 0.22 | -0.19 | N/A | -0.21 |
| EPS Basic Continuous Ops | -0.14 | 0.22 | -0.19 | -0.01 | -0.21 |
| EPS Diluted Total Ops | -0.14 | 0.22 | -0.19 | N/A | -0.21 |
| EPS Diluted Continuous Ops | -0.14 | 0.21 | -0.19 | -0.01 | -0.21 |
| EPS Diluted Before Non-Recurring Items | -0.14 | 0.22 | -0.19 | -0.21 | N/A |
| EBITDA(a) | $-36,245 | $50,407 | $-43,727 | $-51,295 | $-41,911 |